El Khoury AC - Search Results

1

Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans.

Emond B, El Khoury AC, Patel C, Pilon D, Morrison L, Zhdanava M, Lefebvre P, Tandon N, Joshi K. Emond B, et al. Among authors: el khoury ac. Curr Med Res Opin. 2019 Mar;35(3):407-416. doi: 10.1080/03007995.2018.1560220. Epub 2019 Jan 5. Curr Med Res Opin. 2019. PMID: 30556739

2

Transitioning from oral risperidone or paliperidone to once-monthly paliperidone palmitate: a real-world analysis among Veterans Health Administration patients with schizophrenia who have had at least one prior hospitalization.

El Khoury A, Patel C, Huang A, Wang L, Bashyal R. El Khoury A, et al. Curr Med Res Opin. 2019 Dec;35(12):2159-2168. doi: 10.1080/03007995.2019.1651129. Epub 2019 Aug 22. Curr Med Res Opin. 2019. PMID: 31366251 Free article.

3

Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis.

Patel C, El Khoury A, Huang A, Wang L, Baser O, Joshi K. Patel C, et al. Adv Ther. 2019 Oct;36(10):2941-2953. doi: 10.1007/s12325-019-01039-9. Epub 2019 Aug 8. Adv Ther. 2019. PMID: 31396809

4

Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis.

Pilon D, Amos TB, Kamstra R, Manceur AM, El Khoury AC, Lefebvre P. Pilon D, et al. Among authors: el khoury ac. Curr Med Res Opin. 2019 Jan;35(1):41-49. doi: 10.1080/03007995.2018.1512477. Epub 2018 Sep 5. Curr Med Res Opin. 2019. PMID: 30106313

5

Health Care Resource Utilization and Costs Associated with Transitioning to 3-month Paliperidone Palmitate Among US Veterans.

DerSarkissian M, Lefebvre P, Joshi K, Brown B, Lafeuille MH, Bhak RH, Hellstern M, Bobbili P, Shiner B, El Khoury AC, Young-Xu Y. DerSarkissian M, et al. Among authors: el khoury ac. Clin Ther. 2018 Sep;40(9):1496-1508. doi: 10.1016/j.clinthera.2018.07.011. Epub 2018 Aug 23. Clin Ther. 2018. PMID: 30145029 Free article.

6

The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia.

El Khoury AC, Pilon D, Morrison L, Shak N, Vermette-Laforme M, Amos TB, Kim E, Lefebvre P. El Khoury AC, et al. Curr Med Res Opin. 2019 Mar;35(3):395-405. doi: 10.1080/03007995.2018.1558195. Epub 2019 Jan 3. Curr Med Res Opin. 2019. PMID: 30526125

7

Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study.

Cai Q, Patel C, Kim E, Connolly N, Tunceli O, El Khoury AC. Cai Q, et al. Among authors: el khoury ac. Adv Ther. 2019 Apr;36(4):858-869. doi: 10.1007/s12325-019-00913-w. Epub 2019 Mar 8. Adv Ther. 2019. PMID: 30848442

8

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate.

Patel C, Emond B, Lafeuille MH, Côté-Sergent A, Lefebvre P, Tandon N, El Khoury AC. Patel C, et al. Among authors: el khoury ac. Drugs Real World Outcomes. 2020 Mar;7(1):19-29. doi: 10.1007/s40801-019-00172-9. Drugs Real World Outcomes. 2020. PMID: 31786737 Free PMC article.

9

Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia.

El Khoury AC, Pilon D, Morrison L, Shak N, Llaneza A, Kim E, Lefebvre P. El Khoury AC, et al. J Manag Care Spec Pharm. 2020 Feb;26(2):176-185. doi: 10.18553/jmcp.2020.26.2.176. J Manag Care Spec Pharm. 2020. PMID: 32011960 Free PMC article.

10

Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates.

Nuhoho S, Saad A, Saumell G, Ribes D, El Khoury AC. Nuhoho S, et al. Among authors: el khoury ac. Curr Med Res Opin. 2018 Apr;34(4):601-611. doi: 10.1080/03007995.2017.1417246. Epub 2018 Jan 10. Curr Med Res Opin. 2018. PMID: 29292670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters